The company delivered net revenues of $12.310 billion, showing increases in various portfolios.
Adjusted Earnings Will Be $11.19 To $11.23 A Share This Year, Up From The Earlier Range Of $10.86 To $11.06, Abbvie Said Friday In A Statement.
Us$1.37b (up by us$1.14b from 1q 2023).
11% (Up From 1.9% In 1Q.
Images References :
Us$12.3B (Flat On 1Q 2023).
Abbvie reported strong financial results for the first quarter of 2024, with diluted eps of $0.77 on a gaap basis and $2.31 on an adjusted basis.
These Results Include An Unfavorable Impact Of $0.08 Per Share Related To Acquired Ipr&Amp;D And.
11% (up from 1.9% in 1q.
Imbruvica Total Revenue Of $3.1 Billion, An Increase Of $200 Million, Reflecting Lower Erosion And Elahere Total Sales To Abbvie Of $450 Million, An Increase Of Roughly.
